期刊
INFLAMMOPHARMACOLOGY
卷 31, 期 4, 页码 2061-2075出版社
SPRINGER BASEL AG
DOI: 10.1007/s10787-023-01234-9
关键词
Resolvin D1; Neurotoxicity; Autophagy; Sepsis; Depression; Neuroinflammation
It has been discovered that neuroinflammation caused by microglial activation is the cause of depression associated with sepsis. An endogenous lipid mediator called resolvin D1 (RvD1) has anti-inflammatory effects in a sepsis model. However, it is still unclear if the effects of RvD1 on inflammatory responses are regulated by microglial autophagy.
It has been proven that neuroinflammation triggered by microglial activation is the pathogenesis of depression associated with sepsis. An endogenous lipid mediator known as resolvin D1 (RvD1) is known to have anti-inflammatory effects in a sepsis model. However, it remains unknown if the effects of RvD1 on inflammatory responses are regulated by microglial autophagy. The current study investigated the role of RvD1-induced microglial autophagy in neuroinflammation. The findings showed that RvD1 reverses LPS-induced autophagy inhibition in microglia. RvD1 treatment significantly inhibits inflammatory responses by preventing NF-kappa B nuclear translocation and microglial M1 phenotypic transition. RvD1 exhibits an attenuation of neurotoxicity in both in vivo and in vitro models of sepsis. Following RvD1 injection, depressive-like behaviors in SAE mice were significantly improved. Notably, the aforesaid effects of RvD1 were eliminated by 3-MA, demonstrating that microglial autophagy was modulated. In conclusion, our findings shed new light on the involvement of microglial autophagy in SAE and emphasize the potential benefits of RvD1 as a promising therapeutic agent in the treatment of depression.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据